A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease

NCT04520412 · clinicaltrials.gov ↗
PHASE3
Phase
SUSPENDED
Status
2046
Enrollment
INDUSTRY
Sponsor class

Stopped The quality of study was seriously affected by the COVID-19, so it was decided to suspend the trial and restart it at the right time.

Conditions

Interventions

Sponsor

Green Valley (Shanghai) Pharmaceuticals Co., Ltd.